Couples more likely to divorce if spouse develops cervical or testicular cancer

September 27, 2007

Barcelona, Spain: In the largest and most rigorous study to date investigating how cancer influences divorce, Norwegian researchers have found that marriages are no more likely than normal to break down unless a spouse develops cervical or testicular cancer.

In fact, the study, presented today (Thursday 27 September) at the European Cancer Conference (ECCO 14) in Barcelona, found most types of cancer resulted in a slight decrease in the divorce rate in the first few years following the diagnosis.

The research, which compared the divorce rates of 215,000 cancer survivors with those among couples with no cancer over a period of about 17 years, revealed that women who developed cervical cancer were 40 percent more likely than normal to get divorced and testicular cancer survivors were 20 percent more likely to get divorced than similar men without cancer.

The findings also confirmed earlier studies debunking the myth that husbands may be more likely to abandon their wives after breast cancer. Breast cancer survivors saw an eight percent decrease in their divorce risk compared to similar women without the disease.

Mrs Astri Syse, a researcher at the Norwegian Cancer Registry in Oslo, Norway, who led the study, said several factors might explain why divorce risk increased only with cervical and testicular cancer.

The two cancers affect intimacy, resulting in decreases in sexual desire, enjoyment and fertility. However, the study's results were adjusted to take into account any influence of fertility and both cancers tend to be detected early in Norway, resulting in minimal impact from sexually debilitating treatments, Syse noted.

Perhaps the most relevant factor, Syse proposed, is that cervical and testicular cancers mostly affect younger people.

"We suggest that younger age is a stronger predictor than alterations in sexual function," Syse said. "It is also possible that sexual problems or a weakening of the emotional rewards from the union are particularly devastating early in a relationship and that an increased care load is most difficult to accept at an age when illness is most unexpected.

"Women with cervical cancer had an increased risk of divorce of 69% at age 20 years, but this risk was reduced to 19% at 60 years, implying that the effect of cervical cancer on divorce risk decreases with age," Syse said. "The same tendency was seen among men with testicular cancer. The increased risk of divorce was estimated to 34% at 20 years, while it was estimated to fall 16% below the risk of the general population at 60 years."

As for why most cancers resulted in a decrease in divorce risk, Syse said a cancer diagnosis might strengthen the bonds between partners.

"In addition, a serious disease may 'save' an unsatisfactory relationship because a break-up would be considered inappropriate in such a situation, or because an expected fatal outcome will make it 'unnecessary'," said Syse.

The study found that divorce was least likely to occur when the cancer had spread or for types of cancer that have a poor prognosis, and more likely in cancers with a good chance of recovery.
-end-


ECCO-the European CanCer Organisation

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.